Ilovebenefits’s Blog

Just another weblog

Why We Need an Independent Comparative Effectiveness Institute

Data From Studies of Pfizer Neurontin Drug May Have Been Skewed
Bloomberg – November 11, 2009

Researchers say trials of Pfizer Inc.’s Neurontin epilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results.


November 14, 2009 - Posted by | drugs, healthcare, Transparency | , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: